US Patent Issued to Antecip Bioventures II on Nov. 18 for "Compounds and combinations thereof for treating neurological and psychiatric conditions" (New York Inventor)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,156, issued on Nov. 18, was assigned to Antecip Bioventures II LLC (New York).

"Compounds and combinations thereof for treating neurological and psychiatric conditions" was invented by Herriot Tabuteau (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, an antidepressant, such as bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan."

The patent was filed on May 9, 2025, under Application No. 19/204,307.

*For fur...